These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 9436358

  • 1. [Neurotrophic keratopathy--studies on substance P and the clinical significance of corneal sensation].
    Nishida T, Nakamura M, Konma T, Ofuji K, Nagano K, Tanaka T, Enoki M, Reid TW, Brown SM, Murphy CJ, Mannis MJ.
    Nippon Ganka Gakkai Zasshi; 1997 Dec; 101(12):948-74. PubMed ID: 9436358
    [Abstract] [Full Text] [Related]

  • 2. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
    Yamada N, Matsuda R, Morishige N, Yanai R, Chikama TI, Nishida T, Ishimitsu T, Kamiya A.
    Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effect of substance P with epidermal growth factor on epithelial migration in rabbit cornea.
    Nakamura M, Nishida T, Ofuji K, Reid TW, Mannis MJ, Murphy CJ.
    Exp Eye Res; 1997 Sep; 65(3):321-9. PubMed ID: 9299169
    [Abstract] [Full Text] [Related]

  • 4. Peptide therapies for ocular surface disturbances based on fibronectin-integrin interactions.
    Nishida T, Inui M, Nomizu M.
    Prog Retin Eye Res; 2015 Jul; 47():38-63. PubMed ID: 25645519
    [Abstract] [Full Text] [Related]

  • 5. [The cornea: stasis and dynamics].
    Nishida T.
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):179-212; discussion 213. PubMed ID: 18411711
    [Abstract] [Full Text] [Related]

  • 6. Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea.
    Nishida T, Nakamura M, Ofuji K, Reid TW, Mannis MJ, Murphy CJ.
    J Cell Physiol; 1996 Oct; 169(1):159-66. PubMed ID: 8841432
    [Abstract] [Full Text] [Related]

  • 7. Persistent epithelial defects due to neurotrophic keratopathy treated with a substance p-derived peptide and insulin-like growth factor 1.
    Nishida T, Chikama T, Morishige N, Yanai R, Yamada N, Saito J.
    Jpn J Ophthalmol; 2007 Oct; 51(6):442-7. PubMed ID: 18158595
    [Abstract] [Full Text] [Related]

  • 8. Synergistic effect with Phe-Gly-Leu-Met-NH2 of the C-terminal of substance P and insulin-like growth factor-1 on epithelial wound healing of rabbit cornea.
    Nakamura M, Chikama T, Nishida T.
    Br J Pharmacol; 1999 May; 127(2):489-97. PubMed ID: 10385250
    [Abstract] [Full Text] [Related]

  • 9. [Promotion of corneal epithelial wound healing with a tetrapeptide (SSSR) derived from insulin-like growth factor-1].
    Yamada N.
    Nippon Ganka Gakkai Zasshi; 2008 Nov; 112(11):984-93. PubMed ID: 19069381
    [Abstract] [Full Text] [Related]

  • 10. Sensitizing effect of substance P on corneal epithelial migration induced by IGF-1, fibronectin, or interleukin-6.
    Yamada N, Yanai R, Inui M, Nishida T.
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):833-9. PubMed ID: 15728538
    [Abstract] [Full Text] [Related]

  • 11. Role of the C domain of IGFs in synergistic promotion, with a substance P-derived peptide, of rabbit corneal epithelial wound healing.
    Yamada N, Yanai R, Nakamura M, Inui M, Nishida T.
    Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1125-31. PubMed ID: 15037578
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of integrin alpha5 by a C-terminus four-amino-acid sequence of substance P (phenylalanine-glycine-leucine-methionine- amide) synergistically with insulin-like growth factor-1 in SV-40 transformed human corneal epithelial cells.
    Chikama T, Nakamura M, Nishida T.
    Biochem Biophys Res Commun; 1999 Feb 24; 255(3):692-7. PubMed ID: 10049772
    [Abstract] [Full Text] [Related]

  • 13. Promotion of corneal epithelial wound healing by a tetrapeptide (SSSR) derived from IGF-1.
    Yamada N, Yanai R, Kawamoto K, Nagano T, Nakamura M, Inui M, Nishida T.
    Invest Ophthalmol Vis Sci; 2006 Aug 24; 47(8):3286-92. PubMed ID: 16877393
    [Abstract] [Full Text] [Related]

  • 14. Role of the Neurokinin-1 Receptor in the Promotion of Corneal Epithelial Wound Healing by the Peptides FGLM-NH2 and SSSR in Neurotrophic Keratopathy.
    Yanai R, Nishida T, Hatano M, Uchi SH, Yamada N, Kimura K.
    Invest Ophthalmol Vis Sci; 2020 Jul 01; 61(8):29. PubMed ID: 32697304
    [Abstract] [Full Text] [Related]

  • 15. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1.
    Nakamura M, Ofuji K, Chikama T, Nishida T.
    Br J Pharmacol; 1997 Feb 01; 120(4):547-52. PubMed ID: 9051288
    [Abstract] [Full Text] [Related]

  • 16. Advances in treatment for neurotrophic keratopathy.
    Nishida T, Yanai R.
    Curr Opin Ophthalmol; 2009 Jul 01; 20(4):276-81. PubMed ID: 19537364
    [Abstract] [Full Text] [Related]

  • 17. Neurotrophic keratopathy; its pathophysiology and treatment.
    Okada Y, Reinach PS, Kitano A, Shirai K, Kao WW, Saika S.
    Histol Histopathol; 2010 Jun 01; 25(6):771-80. PubMed ID: 20376784
    [Abstract] [Full Text] [Related]

  • 18. Potential New Modes of Treatment of Neurotrophic Keratopathy.
    Yanai R, Nishida T, Chikama T, Morishige N, Yamada N, Sonoda KH.
    Cornea; 2015 Nov 01; 34 Suppl 11():S121-7. PubMed ID: 26448169
    [Abstract] [Full Text] [Related]

  • 19. Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance P-derived peptide (FGLM-NH2) and insulin-like growth factor-1.
    Nakamura M, Kawahara M, Morishige N, Chikama T, Nakata K, Nishida T.
    Diabetologia; 2003 Jun 01; 46(6):839-42. PubMed ID: 12764579
    [Abstract] [Full Text] [Related]

  • 20. Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy.
    Nagano T, Nakamura M, Nakata K, Yamaguchi T, Takase K, Okahara A, Ikuse T, Nishida T.
    Invest Ophthalmol Vis Sci; 2003 Sep 01; 44(9):3810-5. PubMed ID: 12939296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.